0.4 mg Per Container: A Formulator’s Reading of the Cap
The cap is not what most summaries say it is. It is per container, and it is combined. Both details change what you can build.
True to Plant EditorialJuly 17, 2026
True to Plant
Schedule III and Your Supply Chain: A Buyer’s Brief
Rescheduling changed less than the headlines suggested, and what it did change is split by licence type. That split matters for sourcing.
True to Plant EditorialJuly 13, 2026
Does the FDA Flavoured Vape Guidance Reach Hemp Terpenes?
The question comes up in every sourcing call this year. The answer is in the scope of the guidance, and the scope is narrower than the rumour.
True to Plant EditorialJuly 6, 2026
COA, SDS, TDS: The Terpene Documentation Every Brand Should Demand
What COA, SDS, and TDS documents mean, how to read them, and the red flags that tell you a supplier cuts corners.
True to Plant EditorialJuly 1, 2026
Botanical vs Cannabis-Derived vs True To Plant: A Complete Breakdown
A three-way comparison of botanical, cannabis-derived, and True To Plant terpenes: cost, authenticity, legality, and which fits your brand.
True to Plant EditorialJune 29, 2026
How to Evaluate a Terpene Supplier (12-Point Checklist)
Evaluate…
True to Plant EditorialJune 26, 2026
Cannabis Terpene Profiles: What the GC-MS Data Actually Tells You
How to read a terpene GC-MS COA, what the numbers mean for flavor and effect, and what documentation to demand from suppliers.
True to Plant EditorialJune 22, 2026
